REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 122 filers reported holding REVANCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $6,536,000 | -1.4% | 233,841 | 0.0% | 0.51% | +18.7% |
Q4 2020 | $6,627,000 | +12.7% | 233,841 | 0.0% | 0.43% | -16.1% |
Q3 2020 | $5,879,000 | -45.8% | 233,841 | -47.3% | 0.52% | -50.4% |
Q2 2020 | $10,839,000 | +56.0% | 443,841 | -5.4% | 1.04% | +54.2% |
Q1 2020 | $6,946,000 | -9.4% | 469,332 | -0.7% | 0.68% | +5.8% |
Q4 2019 | $7,669,000 | +24.8% | 472,532 | 0.0% | 0.64% | -6.3% |
Q3 2019 | $6,143,000 | +0.2% | 472,532 | 0.0% | 0.68% | +68.1% |
Q2 2019 | $6,129,000 | -17.7% | 472,532 | 0.0% | 0.40% | -14.4% |
Q1 2019 | $7,447,000 | -21.7% | 472,532 | 0.0% | 0.47% | -16.7% |
Q4 2018 | $9,512,000 | -19.0% | 472,532 | 0.0% | 0.57% | +0.9% |
Q3 2018 | $11,742,000 | -9.5% | 472,532 | 0.0% | 0.56% | -15.0% |
Q2 2018 | $12,971,000 | +31.9% | 472,532 | +48.0% | 0.66% | +6.9% |
Q1 2018 | $9,835,000 | – | 319,313 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |